Can AI actually lower the cost of IVF treatment? A newly published study in F&S Reports suggests it can. Led by Dr. Brad Miller at Reproductive Medicine Associates of Michigan, this research demonstrates how his team used Alife's AI-powered Stim Assist tool to guide ovarian stimulation and trigger timing, resulting in significantly reduced medication costs, all while maintaining successful outcomes.
Be part of the conversation as Dr. Miller walks through the data, shares his insights, and answers your questions live.
Can't make it live? Register anyway, and we'll send you the recording!
Key takeaways from the newly published study
Why he uses an AI support tool and how it has benefitted his practice
A look towards the future and what new AI innovations he expects to enter clinics
Live audience Q&A
Dr. Miller is a board-certified reproductive endocrinologist and founder of RMA of Michigan. Previously, he was a partner at RMA of New Jersey, working with Dr. Richard Scott and gaining extensive experience, including over 35,000 ultrasounds, 2,000 oocyte retrievals, and 4,000 embryo transfers. His patients have delivered over 1,500 babies, with 70% singletons.
A U.S. Navy veteran, Dr. Miller directed the ART Program at Walter Reed and NIH, making it one of the most successful in the Washington, DC area. He earned his medical degree from Wayne State University and completed his residency at the National Naval Medical Center, followed by a fellowship at NIH. An accomplished researcher, he has authored over 20 scientific articles and received multiple military achievement medals. He also serves on the AOA selection committee and volunteers at the Gary Burnstein Community Health Clinic.